Contec Medical Systems Co.,Ltd (SHE:300869)
China flag China · Delayed Price · Currency is CNY
9.47
-0.33 (-3.37%)
Nov 13, 2026, 3:04 PM CST

SHE:300869 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Net Income
-91.11-24.42-77.9165.77196.2352.35
Depreciation & Amortization
27.3227.3827.9527.5220.5917.86
Other Amortization
0.240.170.02---
Loss (Gain) From Sale of Assets
0.170.170.090.070.260.04
Asset Writedown & Restructuring Costs
----0.0110.72
Loss (Gain) From Sale of Investments
-18.5-18.5-24.11-13.49-54.6-1.58
Provision & Write-off of Bad Debts
-1.35-1.351.44-1.032.020.38
Other Operating Activities
103.648.88109.132.7-40.98-115.35
Change in Accounts Receivable
-10.46-10.46-13.88148.68-64.49-23.01
Change in Inventory
14.5914.5974.03-85.05-17.39-144.98
Change in Accounts Payable
-10.72-10.72-36.56-78.359.34-93.11
Operating Cash Flow
10.3322.2962.34181.01103.664.65
Operating Cash Flow Growth
-77.91%-64.25%-65.56%74.63%2130.42%-99.22%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Capital Expenditures
-23.51-49.48-54.46-30.74-81.45-106.31
Sale of Property, Plant & Equipment
0.110.140.950.110.250.12
Investment in Securities
484.85224.85-170.24-750-5050
Other Investing Activities
-953.4252.27118.0857.6717.375.09
Investing Cash Flow
-491.96227.79-105.68-722.96-113.82-51.09

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Short-Term Debt Issued
-27590632.88874.88915.2
Long-Term Debt Issued
----690.1-
Total Debt Issued
7327590632.881,565915.2
Short-Term Debt Repaid
--120-377-1.06-787.05-312.1
Long-Term Debt Repaid
--1.43-2.21-1,191-1.87-0.35
Lease Payments
-0.51-1.43-2.21-2.1-1.87-0.35
Total Debt Repaid
-225.51-121.43-379.21-1,192-788.92-312.45
Net Debt Issued (Repaid)
-152.51153.57-289.21-559.54776.06602.75
Common Dividends Paid
-16.28-112.11-127.72-68.7-123.92-102.31
Other Financing Activities
-0.8222.06673.18244.79129.2-666.06
Financing Cash Flow
-169.6163.52256.26-383.44781.34-165.62

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Foreign Exchange Rate Adjustments
-46.54-15.184.165.2817.58-2.5
Net Cash Flow
-697.79298.42217.08-920.1788.75-214.56

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Free Cash Flow
-13.18-27.197.88150.2822.21-101.66
Free Cash Flow Growth
---94.75%576.62%--
Free Cash Flow Margin
-2.76%-5.81%1.64%20.12%3.12%-11.19%
Free Cash Flow Per Share
-0.03-0.070.020.360.05-0.25
Levered Free Cash Flow
-14.63411.69-449.4870.11-46.16-97.74
Unlevered Free Cash Flow
-12.96435.09-427.4298.3-34.24-95.95
Free Cash Flow After Leases
-13.68-28.625.67148.1720.34-102.01

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Cash Income Tax Paid
-7.7440.6934.949.960.8
Change in Working Capital
-10.03-10.0325.77-30.52-19.85-259.78